Novo Nordisk's shares plunged more than 20% Tuesday, after the company cut the forecast for its flagship obesity drug. Before the markets opened, the company announced that sales of its obesity ...
Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine.... Novo Nordisk's shares plunged more than 20% Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback